首页 > 市场调查报告书 > 製药

临床开发

全球小鼠模型技术市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

市场调查报告书

商品编码

1342841

全球小鼠模型技术市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Mice Model Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球小鼠模型技术市场需求预计将从 2022 年的 50.4 亿美元增至 2030 年的近 125.2 亿美元，2023-2030 年研究期间复合年增长率为 10.64%。

小鼠模型技术使用不同的小鼠物种来模拟人类发现的生物过程或疾病的特征。这些技术之所以变得流行，是因为小鼠与人类具有哺乳动物的特征，并且患有许多类似的疾病。小鼠模型技术对于生物医学研究非常有益。基因工程用于开发不同类型的小鼠模型，以针对特定的人类状况。

市场动态：

基因编辑工具的进步以及人类和小鼠之间生理相似性的提高是增加对小鼠模型技术需求的主要因素。不利的一面是，各国政府实施的严格法规和指导方针以及一些组织对小鼠测试的日益反对可能会限制市场扩张。儘管如此，对人性化小鼠模型的需求不断增长以及个性化医疗消费的增加可能会对小鼠模型技术市场产生积极影响。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球小鼠模型技术市场的每个细分市场进行了包容性评估。小鼠模型技术行业的增长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的小鼠模型技术市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。小鼠模型技术市场的主要参与者包括Biocytogen、Charles River Laboratories、Cyagen Biosciences、Gempharmatech、genOway、ingenious Targeting Laboratory、Merck KGaA、Ozgene Pty Ltd.、Taconic Biosciences Inc.、PolyGene AG、The Jackson 实验室、耶鲁大学医学院医学，北卡罗来纳大学，内布拉斯加大学医学中心，莫纳什大学，麻省大学陈医学院，波恩大学，哥伦比亚大学，亚利桑那大学。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

区域展望
介绍
北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家/地区销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家/地区销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家/地区销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：MICE 模型技术公司的竞争格局

小鼠模型技术市场竞赛
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市场份额分析
市场集中度
Biocytogen

公司简介
公司收入
产品
最近的发展

Charles River Laboratories

公司简介
公司收入
产品
最近的发展

Cyagen Biosciences

公司简介
公司收入
产品
最近的发展

Gempharmatech

公司简介
公司收入
产品
最近的发展

genOway

公司简介
公司收入
产品
最近的发展

ingenious targeting laboratory

公司简介
公司收入
产品
最近的发展

Merck KGaA

公司简介
公司收入
产品
最近的发展

Ozgene Pty Ltd.

公司简介
公司收入
产品
最近的发展

Taconic Biosciences Inc.

公司简介
公司收入
产品
最近的发展

PolyGene AG

公司简介
公司收入
产品
最近的发展

The Jackson laboratory

公司简介
公司收入
产品
最近的发展

Yale School of Medicine

公司简介
公司收入
产品
最近的发展

University of North Carolina

公司简介
公司收入
产品
最近的发展

University of Nebraska Medical Center

公司简介
公司收入
产品
最近的发展

Monash University

公司简介
公司收入
产品
最近的发展

UMass Chan Medical School

公司简介
公司收入
产品
最近的发展

University of Bonn

公司简介
公司收入
产品
最近的发展

Columbia University

公司简介
公司收入
产品
最近的发展

The University of Arizona

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

简介目录图表

Product Code: VMR11219536

The global demand for Mice Model Technologies Market is presumed to reach the market size of nearly USD 12.52 BN by 2030 from USD 5.04 BN in 2022 with a CAGR of 10.64% under the study period 2023 - 2030.

Mice model technologies use different mice species in order to mimic characteristics of a biological process or a disease found in humans. These technologies have become popular because mice share mammalian features with humans and suffer from many similar diseases. Mice model technologies are highly beneficial for biomedical research. Genetic engineering is used to develop different types of mice models to target specific human conditions.

MARKET DYNAMICS:

The rise in the advancements in gene editing tools and physiological similarities between humans and mice are major factors augmenting the demand for mice model technologies. On the downside, strict regulations and guidelines imposed by various governments and growing opposition to mice testing by several organizations may restrict market expansion. Nonetheless, rising demand for humanized mouse models and increasing consumption of personalized medicine will likely impact the mice model technologies market positively.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of mice model technologies. The growth and trends of mice model technologies industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the mice model technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

CRISPR Knockout
CRISPR Knockin
Random Insertions
Large, Targeted Insertions
ES Cell Modification (Homologous Recombination)
Others

By End-User

Pharmaceutical Companies
Biotechnology Companies
Academic And Research Facilities
Contract Research And Manufacturing Organizations

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Mice Model Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the mice model technologies market include Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd., Taconic Biosciences Inc., PolyGene AG, The Jackson laboratory, Yale School of Medicine, University of North Carolina, University of Nebraska Medical Center, Monash University, UMass Chan Medical School, University of Bonn, Columbia University, The University of Arizona. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . MICE MODEL TECHNOLOGIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By End-user
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 CRISPR Knockout Historic and Forecast Sales by Regions
6.5 CRISPR Knockin Historic and Forecast Sales by Regions
6.6 Random Insertions Historic and Forecast Sales by Regions
6.7 Large, Targeted Insertions Historic and Forecast Sales by Regions
6.8 ES Cell Modification (Homologous Recombination) Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
7.5 Biotechnology Companies Historic and Forecast Sales by Regions
7.6 Academic And Research Facilities Historic and Forecast Sales by Regions
7.7 Contract Research And Manufacturing Organizations Historic and Forecast Sales by Regions

8 . GLOBAL MICE MODEL TECHNOLOGIES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE MICE MODEL TECHNOLOGIES COMPANIES

9.1. Mice Model Technologies Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF MICE MODEL TECHNOLOGIES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Biocytogen
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Charles River Laboratories
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Cyagen Biosciences
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Gempharmatech
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. genOway
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. ingenious targeting laboratory
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Merck KGaA
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Ozgene Pty Ltd.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Taconic Biosciences Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. PolyGene AG
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. The Jackson laboratory
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments
10.14. Yale School of Medicine
- 10.14.1. Company Overview
- 10.14.2. Company Revenue
- 10.14.3. Products
- 10.14.4. Recent Developments
10.15. University of North Carolina
- 10.15.1. Company Overview
- 10.15.2. Company Revenue
- 10.15.3. Products
- 10.15.4. Recent Developments
10.16. University of Nebraska Medical Center
- 10.16.1. Company Overview
- 10.16.2. Company Revenue
- 10.16.3. Products
- 10.16.4. Recent Developments
10.17. Monash University
- 10.17.1. Company Overview
- 10.17.2. Company Revenue
- 10.17.3. Products
- 10.17.4. Recent Developments
10.18. UMass Chan Medical School
- 10.18.1. Company Overview
- 10.18.2. Company Revenue
- 10.18.3. Products
- 10.18.4. Recent Developments
10.19. University of Bonn
- 10.19.1. Company Overview
- 10.19.2. Company Revenue
- 10.19.3. Products
- 10.19.4. Recent Developments
10.20. Columbia University
- 10.20.1. Company Overview
- 10.20.2. Company Revenue
- 10.20.3. Products
- 10.20.4. Recent Developments
10.21. The University of Arizona
- 10.21.1. Company Overview
- 10.21.2. Company Revenue
- 10.21.3. Products
- 10.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Technology (USD MN)
CRISPR Knockout Market Sales by Geography (USD MN)
CRISPR Knockin Market Sales by Geography (USD MN)
Random Insertions Market Sales by Geography (USD MN)
Large, Targeted Insertions Market Sales by Geography (USD MN)
ES Cell Modification (Homologous Recombination) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by End-user (USD MN)
Pharmaceutical Companies Market Sales by Geography (USD MN)
Biotechnology Companies Market Sales by Geography (USD MN)
Academic And Research Facilities Market Sales by Geography (USD MN)
Contract Research And Manufacturing Organizations Market Sales by Geography (USD MN)
Global Mice Model Technologies Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Mice Model Technologies Report
Market Research Process
Market Research Methodology
Global Mice Model Technologies Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Technology
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Technology (USD MN)
CRISPR Knockout Market Sales by Geography (USD MN)
CRISPR Knockin Market Sales by Geography (USD MN)
Random Insertions Market Sales by Geography (USD MN)
Large, Targeted Insertions Market Sales by Geography (USD MN)
ES Cell Modification (Homologous Recombination) Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Pharmaceutical Companies Market Sales by Geography (USD MN)
Biotechnology Companies Market Sales by Geography (USD MN)
Academic And Research Facilities Market Sales by Geography (USD MN)
Contract Research And Manufacturing Organizations Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Companies Market Share Analysis